36C24418Q0087-000.docx

FedBizOpps Combined Synopsis/Solicitation Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

RESPONSE DATE (MM-DD-YYYY)

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

SET-ASIDE

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

GENERAL INFORMATION

PLACE OF PERFORMANCE

* = Required Field FedBizOpps Combined Synopsis/Solicitation Notice Rev. March 2010 Provision of Histology Staining Reagents to the VA Pittsburgh Healthcare System's (VAPHS) Pathology & Laboratory Medicine Service (P&LM).

19320 36C24418Q0087 01-17-2018 N 325413 Department of Veterans Affairs Network Contracting Office 4 Attn: Matthew D. Parlett (90C) 1400 Blackhorse Hill Road Coatesville, PA 19320-2096 Matthew D. Parlett Contracting Officer

610.384.7711 EXT 3233

matthew.parlett@va.gov Department of Veterans Affairs VA Pittsburgh Healthcare System Pathology & Laboratory Medicine - Histology University Drive C Pittsburgh 15240-1004

USA

matthew.parlett@va.gov The VAPHS P&LM is requesting award of a fixed price, Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a five year ordering period. Contract type was selected as the Government cannot adequately predict the exact number of reagents that will be needed in any given period of time. Award is to be made on an open market, unrestricted competitive basis. Said contract will provide the means for expeditious ordering and supply of antibodies, special stains, cell conditioners, and other associated histology reagents for use in conjunction with their existing Roche Diagnostics Corporation, Ventana histology staining platform (equipment) for the performance of, immunohistochemistry, in situ hybridization (IHC/IHS) studies. These studies are used in the specific diagnosis of both common and rare tumors encountered in human tissues. Note that this procurement will allow competing offerors to offer histology reagents that are brand name or equal to the Roche/Ventana reagents currently in use by the VAPHS P&LM and will also allow offerors whose equal reagents are not compatible with the existing equipment to offer their own staining platform(s) for consideration.

See attached document: 36C244-18-Q-0087 Histology Staining Reagents VAPHS P_LM v.3.

End of Document